Načítá se...
Targeting IL-4 for the Treatment of Atopic Dermatitis
Atopic dermatitis (AD) is an immune-mediated inflammatory skin disease characterized by a predominant type 2 immune response. Type 2 immunity is driven by multiple cytokines, including interleukin (IL)‑4 and IL-13 that are considered central to AD pathogenesis and key therapeutic targets. The dual i...
Uloženo v:
| Vydáno v: | Immunotargets Ther |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7532907/ https://ncbi.nlm.nih.gov/pubmed/33062619 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/ITT.S260370 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|